Details
| Original language | English |
|---|---|
| Pages (from-to) | 1129-1131 |
| Number of pages | 3 |
| Journal | International Journal of Cardiology |
| Volume | 176 |
| Issue number | 3 |
| Publication status | Published - 20 Oct 2014 |
Keywords
- ADMA, Cardiovascular disease, Homoarginine, Rheumatoid arthritis
ASJC Scopus subject areas
- Medicine(all)
- Cardiology and Cardiovascular Medicine
Sustainable Development Goals
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: International Journal of Cardiology, Vol. 176, No. 3, 20.10.2014, p. 1129-1131.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA?
AU - Kayacelebi, A.A.
AU - Pham, V.V.
AU - Willers, J.
AU - Hahn, Andreas
AU - Stichtenoth, D.O.
AU - Jordan, J.
AU - Tsikas, D.
N1 - Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2014/10/20
Y1 - 2014/10/20
KW - ADMA
KW - Cardiovascular disease
KW - Homoarginine
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=84908208988&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2014.07.296
DO - 10.1016/j.ijcard.2014.07.296
M3 - Article
VL - 176
SP - 1129
EP - 1131
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
IS - 3
ER -